Contraceptive behavior in the developing world has changed markedly over the past three decades. Around 1960 only a tiny fraction of couples practiced contraception, and knowledge of methods was very limited. In contrast, contraceptive knowledge is now widespread and more than half of married women in the developing world are current users of contraception. The large majority of these users rely on modern methods, including male and female sterilization, the IUD, and the pill. This revolution in contraceptive behavior has been driven by a desire to reduce family size, as social and economic changes have increased the cost of children and reduced their benefits. Another key factor contributing to this rise in contraception has been the diffusion of information about and access to contraceptive methods, aided by a rapid expansion of family planning programs. This expansion of access to a range of methods has helped couples implement their preferences for smaller families and avoid unwanted pregnancies.
While past trends in contraceptive behavior are fairly well established, there is uncertainty about what lies ahead. Because contraceptive prevalence levels among married women of reproductive age in many developing countries are approaching levels often found in the industrialized world, one might conclude that contraceptive demand is about to level off. Although future increases in contraceptive use could well occur at a slower pace than heretofore, a further expansion of demand is likely for two reasons.
First, the fertility transition in the developing world is not yet complete. The average number of children per woman has declined from six to three since 1960, but this still leaves fertility about 50 percent above the replacement level of about two children that is expected to prevail in the long run. These further fertility declines will almost certainly be achieved by additional increases in the practice of contraception. Second, as population growth continues, the number of women of reproductive age (15-49 years) is expected to rise in most developing countries. These two factors will drive up the number of users of contraception in the developing world for the next few decades. In contrast, the demand for contraception in the industrial world will likely see little rise in aggregate because neither the level of fertility nor the number of women in the reproductive ages is expected to change much from current levels. However, in specific countries prevalence could rise, in particular where levels of abortion are high (e.g., in Eastern Europe and Japan). In addition, the method mix could well change substantially in both the industrial and the developing world. Such a change would occur even if no additional methods are made available, and it will likely be accelerated by the prospect of new contraceptive technologies.
To assess prospects for future trends in contraceptive use, projections have been made recently by the United Nations (1999a) and the Futures Group (Ross et al. 1999 ).
The UN projects numbers of users for different world regions from 1993 to 2025. The Futures Group provides similar results for individual developing countries to 2015, and also projects numbers of users of different methods. The main objectives of this paper are to review the methodologies used in these projections, evaluate their results, propose methodological improvements, and assess the prospects for new methods of contraception in the coming decade. Before analyzing these projections we summarize past trends because they provide the basis for the projections. The focus throughout is on the developing world.
LEVELS AND TRENDS IN CONTRACEPTIVE PREVALENCE AND METHOD MIX Prevalence
Figure 1 plots estimates of contraceptive prevalence (i.e., the percentage practicing a method among women who are married or in union) for the developing and industrial worlds as well as for selected regions for the latest available year, 1993 (UN 1999a).
For the developing world as a whole, prevalence in 1993 stood at 55 percent. This is 15 percentage points less than the estimate of 70 percent for the industrial world in the same year. The developing-world average is heavily influenced by the high prevalence in China (83 percent); without China, this average would have been only 43 percent.
Sharp differences between regions are evident, with prevalence ranging from 20 percent in Africa to 66 percent in Latin America. If, as seems likely, fertility has continued to decline since 1993, then prevalence today should be a few percentage points higher than in 1993. In fact, the developing-world average (including China) in 2000 is estimated at 60 percent (UN 1999a).
Past trends in contraceptive prevalence for 98 developing countries are plotted in been a pervasive upward trend in prevalence over the past quarter-century. This trend is evident in most countries into the 1990s, except in populations where prevalence remains low (mostly in sub-Saharan Africa).
3) The number of countries for which prevalence estimates are available is greatest in the late 1980s and early 1990s and decreases for earlier dates. The relatively small number of countries with estimates for the 1960s and 1970s tend to be selected for higher-than-average prevalence (UN 1999a). It is therefore difficult to obtain unbiased estimates of global and regional averages for the past. It is possible to obtain indirect estimates through backward projection, but this approach has not been implemented systematically (Bongaarts 1984) .
Contraceptive methods
Methods of contraception practiced today include "modern" and "traditional" Latin America, and they are more likely to rely on the pill or traditional methods. Sterilization is about equally common in Asia and Latin America, but in Asia the prevalence of the IUD is much higher and pill use lower than in Latin America.
At the country level, variation in method mix is even greater than at the regional level. This is illustrated in Figure 4 , which presents levels and past trends for one methodfemale sterilization-for 98 countries. The proportion of users relying on female sterilization ranges from a tiny percentage in a few countries (mostly in Africa) to well over 2015, compared to a rise of 34 percent projected by the UN. These results are due to differences in projection methodology, which will be explored further below. 
Why the number of users keeps rising
An obvious cause of future increases in the number of users in the developing world is the rise in contraceptive prevalence that presumably will accompany anticipated further declines in desired fertility. Several other variables, however, also affect the future number of users. Specifically, the projected growth in contraceptive users over any time interval in any country is attributable to changes in one or more of the following five factors: The number of users (U) at any point in time is the product of these five factors: The specific contributions of the factors (P, F, M, C, and T) to future increases in the number of users can be measured by comparing the percent increase or decrease in each over the projection period 2000 to 2025. These estimates are provided in Table 2 .
For the developing world as a whole, the number of users is projected to be 48.6 percent higher in 2025 than in 2000. This rise is largely attributable to anticipated increases in population size (35.8 percent) and in contraceptive prevalence (12.6 percent). The re-maining factors F, M, and T have substantially smaller effects (-3.1, -3.9, and 4.3 percent, respectively) and they partly offset one another. This same analysis of the roles of different factors has been conducted separately for Africa, Asia, and Latin America (see Table 2 ). Future increases in population size and contraceptive prevalence are also the dominant causes of future increases in users in each region. This is especially the case in Africa, where the huge expected increase in the number of users (253.7 percent) is much higher than the average for the developing world. This difference between Africa and other regions is attributable primarily to much more rapid-than-average increases in population size (65.5 percent) and in prevalence (85.2 percent).
A comment on projection methodology
A projection of the future number of users in a population can be made by prepar- of total users to the number of married users is similar. 1 However, the two agencies differ significantly in the way future trends in contraceptive prevalence are projected, and a brief comment on this difference is in order.
The UN and the Futures Group both assume that future trends in prevalence can be derived from future trends in fertility and that the level of fertility will change (mostly decline) over time as predicted in the standard UN population projections. Given these assumptions, the question is how to turn a fertility trend that is presumed known into a contraceptive prevalence trend.
The Futures Group's procedure for projecting prevalence trends is based on the well-established close statistical relationship between levels of prevalence and fertility (as measured by the total fertility rate, TFR). lence is clearly high (r=0.90), which is not surprising since the practice of contraception is the main proximate determinant of fertility (Bongaarts and Potter 1983) . Variations around the regression line in Figure 5 are due to measurement errors as well as to variations in a number of other proximate determinants that also influence fertility (e.g., the proportion of women in union and the propensity to rely on induced abortion). It is also evident from the figure that the lines representing the different past country experiences generally run parallel to the regression line. This implies that, as expected, a decline in fertility is almost always accompanied by a rise in prevalence. There is some convergence to the regression line as prevalence rises-that is, the variation around the regression line declines at lower levels of fertility. The Futures Group relies on these features to estimate future trends in prevalence from fertility trends. In other words, any country that is now located above or below the regression line is expected to be on this line when the TFR reaches 2 births per woman at some future time. The rate at which a country moves along this trajectory over time depends on the trend in the total fertility rate (which is taken from the standard UN population projections). If a country's TFR does not decline to 2 by 2015, it completes only part of the trajectory and prevalence remains below 72.5 percent in 2015.
The UN's procedure is more complex and, among other things, takes into account differences in contraceptive effectiveness. However, the basic principle on which it is based is easily demonstrated for a hypothetical country with an average level of contraceptive effectiveness. The UN assumes that such a country moves over time from its current level of prevalence and fertility toward a prevalence level of 100 percent when the TFR reaches zero births per woman. 2 For example, a country located at point B in Figure 6 in 2000 (TFR=3, C= 50 percent) would move along a linear trajectory toward point C (TFR=0, C=100 percent). Since no country is expected to reach zero fertility, only part of the path BC is traversed by countries over the next quarter-century.
In general, the UN projects a slightly lower future level of prevalence than the Futures Group for countries that are located below the regression line at the beginning of the projection and a somewhat higher trajectory for those that start above this line. Since there are roughly as many countries above as below the regression line, the average trend for the two projections is similar.
For most countries the procedures followed by the two organizations provide plausible projections. The results are generally similar for countries that fall on or near the regression line at the start of the projection. The main differences occur in countries that are near the end of the fertility transition but are still some distance from the regression line (e.g., point D in Figure 6 ). In such cases the Futures Group procedure typically projects a fairly sharp change in the trend (path DA) compared with the past, while the UN's projection (path DC) represents a smoother transition. The UN also takes into account differences in contraceptive effectiveness and assumes modest improvements in effectiveness over time. These desirable features should improve the accuracy of UN's projections. 
FUTURE TRENDS IN CONTRACEPTIVE METHOD

DISTRIBUTION
Results from recent projections
The Futures Group is the only organization that makes projections of the distribution of contraceptive methods used by women. According to these projections substantial changes will occur in the method mix by 2015 (see Table 3 ). For the developing world as a whole, at least a doubling is expected between 1993 and 2015 for the proportion of users relying on the condom (from 4 to 10 percent) and the pill (from 11 to 22 percent). Increases are also expected for traditional methods (from 9 to 14 percent), injectables (from 4 to 6 percent), and vaginal methods (from 0.3 to 0.6 percent). However, substantial declines are forecast by 2015 for the proportion relying on female sterilization (from 39 to 26 percent), male sterilization (from 8 to 3 percent), and for the IUD (from 26 to 18 percent). These projections indicate a continuation of past trends (1980-93) for the IUD, male sterilization, and vaginal methods, but for all other methods the Futures Group expects reversals of past trends. Some of these results are surprising, especially the sharp drop in female sterilization and the rise in traditional methods. There are no obvious reasons to expect such large reversals. In our view, these projections are not optimally designed in some respects, and we will propose changes in the projection procedures. Before turning to these methodological issues we briefly describe the factors that might affect trends in method choice.
Determinants of method choice
The mix of contraceptive methods selected by couples who wish to avoid pregnancy will continue to evolve in response to changes in several factors: Trends in these three general factors will result in future changes in the mix of methods used by couples in the developing world. Although changes will vary from country to country, it is likely that in most countries the dominant methods will become somewhat less prevalent and the other less-used methods will rise in prevalence. It is important to note, however, that such changes typically occur rather slowly.
A comment on methodology
A full discussion of the methodology employed by the Futures Group is beyond the scope of this paper. Instead, we illustrate the main features of the projection procedure for one method-female sterilization. Table 3 ).
An alternative projection
The preceding comments suggest the following desirable characteristics for a methodology that projects the method mix within countries. First, convergence to a more balanced method mix is likely to occur, but it seems important to allow for considerable inertia. In the past the distribution of methods changed only slowly over time in most countries and the mix at one point in time was highly correlated with the mix 10 or 15 years later. 3 In the Futures Group's procedure this correlation largely disappears between 2000 and 2015. Second, countries will not all reach the same method distribution in 2015. A range of historical, cultural, socioeconomic, and other factors have contributed to the preference of some methods over others in the past. Although such preferences might well diminish in the future, they will almost certainly not disappear altogether. Third, there seems to be little justification for using different projection procedures for different groups of countries. Instead, the fact that a country has a particular charac-teristic (e.g., Muslim) can be considered as one of several factors that lead to current preferences for a particular mix in that country. This preference should be maintained to some degree in the future. Fourth, declines in traditional methods can be expected in the future and this trend should be explicitly acknowledged. percent. These trends seem plausible, although any projection is subject to potentially substantial errors.
The simple alternative procedure presented here should be considered to be no more than a first step toward a detailed and comprehensive methodology for projecting method distribution. Given the scant attention in the literature to the causes of variation in method mix, it is not clear which refinement would improve the accuracy of these projections. Further methodological developments will no doubt benefit from more indepth studies of the factors affecting choice of methods in specific countries (see Potter 1999 for an excellent example).
PROSPECTS FOR NEW CONTRACEPTIVE TECHNOLOGY
A new method requires many years to gain general acceptance, because the contraceptive market moves slowly and is conservative 4 (see Figure 8 ). For example, the first market approval of a copper IUD occurred in 1971, but almost two decades passed before the device became the most widely used contraceptive after female sterilization.
During this period, the copper IUD was greatly improved both in efficacy and duration of use. A similarly slow evolution has occurred in the case of oral contraceptives. The oral contraceptive available to women worldwide in 2000 is very different from the pill first introduced in the United States in the 1960s. The dosage has been drastically reduced, the steroids used are different, and the greater knowledge of the pill's biological effects enables providers to counsel users more thoroughly.
From a market perspective, female sterilization and vasectomy differ from the other modern methods because sterilization is not a product provided by any manufacturer. The development of improved surgical methods has reduced the surgical trauma and time required for the procedure. However, the efficacy and safety of sterilization are largely dependent on the skill of the provider and the quality of the institutions offering the supporting services, such as anesthesia, blood supply, and sterilization of the surgi- In most countries, women are increasingly able to choose good alternative contraceptives developed during the last two decades. There are now four long-term reversible contraceptive products that are virtually as effective as female sterilization. Table 4 lists their generic and trade names, protection times, and approximate number of users worldwide. 1) The copper IUD is the most commonly used long-term reversible contraceptive, and the most affordable one ever developed. The cost of the device when bought in large quantities from the manufacturer is very low (around US $1.00). In fact it is unlikely that any long-term method with such low cost per year of protection will ever be developed again. The IUD with greatest efficacy is the copper T 380A. This method is convenient, but increases menstrual blood loss and menstrual pain. The hormonal methods, on the other hand, reduce these side effects.
2) Norplant ® , the first hormonal implant developed for female contraception, has been found acceptable in most cultures. Having gained approval in 60 countries including the United States, Norplant is effective and safe but requires trained providers for both insertion and removal. Its main disadvantage for the user is unpredictable vaginal bleeding, which, however, tends to be light and is accompanied by little or no pain. A number of new hormonal implant methods are expected to become available in the near future (see Table 5 ). Jadelle ® consists of two levonorgestrel rods that offer effective 3) Mirena ® is a levonorgestrel-releasing intrauterine system that is highly effective for at least five years. It also provides significant health benefits, including drastic Long-term hormonal contraceptive use is likely to grow in the future. Mirena is being introduced in developing countries, and the monthly injectable is already popular in Latin America. Within our time frame (2015), cost will be a limiting factor for widespread use of hormonal contraception in developing countries. However, with extensive use in the developed world, the cost is likely to decrease. The popularity of these contraceptives will also depend on a shift in attitude toward changes in menstrual bleeding these bleedings, therefore, may be manipulated at will. Women in Europe also realize that the collecting of menstrual blood is a cumbersome procedure that limits their mobility and social life (Kristjansdottir et al. 2000) . However, the liberation of women from the burden of menstruation will likely be slow-following improvements in education and in the availability of methods that reliably suppress bleeding. Predictability will be the main selling point. Unfortunately, most currently available methods generally offer poor predictability for women.
Other hormonal methods now under development are expected to become available in the next decade. Hormonal contraception will soon be available in the form of patches, utilizing the transdermal route of administration with a mode of action similar to that of oral contraception. A weekly patch is likely to improve compliance, the lack of which is the main drawback of oral contraceptives. In the foreseeable future, women will be able to choose vaginal rings that provide hormonal contraception in much the same way as oral contraceptives, but without the first-pass metabolic effects on the liver that occur with oral delivery. In clinical trials vaginal rings give excellent bleeding control and are well accepted by women.
Emergency contraceptives in the form of hormones or copper IUDs will be widely used in the future. Copper IUDs are very effective in preventing a pregnancy up to five days after unprotected coitus. Hormonal tablets are less effective and should be taken as soon as possible after coitus. In the next decade specially designed emergency contraceptives will be on the market; these new products will be more effective and will have fewer side effects. Widespread availability and use of emergency contraceptives are likely to reduce the need for induced abortions.
We expect that medical abortion will become much more widely available within a few years. Mifepristone in combination with misoprostol is now widely used for medi- 
CONCLUSION
The number of users of contraception in the developing world is expected to rise from 549 million to 816 million over the next 25 years according to the most recent UN
projection. An examination of the projection methodology found it to be reasonable.
The two main factors driving this increase were identified as the growth in population size (and hence the number of women of reproductive age) and the rise in the contracep-tive prevalence level that will accompany further declines in fertility. The rate of growth in users will be much more rapid in Africa than in Asia or Latin America, because growth in both factors will be higher in Africa than elsewhere.
Projecting the future distribution of specific contraceptive methods is more difficult. Method choice is affected by trends in several factors, including access to different methods, user characteristics, and technology. In addition, the health effects of contraceptives will become a more important consideration to women and men in the future, because contraceptives will be used during a large proportion of the reproductive years.
We expect the mix of contraceptives to change slowly over the coming years. 
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No specific assumptions are made about trends beyond 2015, but it seems unlikely that they will continue along the pre-2015 trajectory.
